Acute subdural hematoma in the elderly: outcome analysis in a retrospective multicentric series of 213 patients.

ASDH = acute subdural hematoma BMT = best medical treatment CCI = Charlson Comorbidity Index CSDH = chronic subdural hematoma DC = decompressive craniectomy GCS = Glasgow Coma Scale GOS = Glasgow Outcome Scale acute subdural hematoma antithrombotic drugs comorbidity elderly surgery traumatic brain injury

Journal

Neurosurgical focus
ISSN: 1092-0684
Titre abrégé: Neurosurg Focus
Pays: United States
ID NLM: 100896471

Informations de publication

Date de publication:
10 2020
Historique:
received: 27 05 2020
accepted: 17 07 2020
entrez: 1 10 2020
pubmed: 2 10 2020
medline: 30 9 2021
Statut: ppublish

Résumé

The objective of this study was to analyze the risk factors associated with the outcome of acute subdural hematoma (ASDH) in elderly patients treated either surgically or nonsurgically. The authors performed a retrospective multicentric analysis of clinical and radiological data on patients aged ≥ 70 years who had been consecutively admitted to the neurosurgical department of 5 Italian hospitals for the management of posttraumatic ASDH in a 3-year period. Outcome was measured according to the Glasgow Outcome Scale (GOS) at discharge and at 6 months' follow-up. A GOS score of 1-3 was defined as a poor outcome and a GOS score of 4-5 as a good outcome. Univariate and multivariate statistics were used to determine outcome predictors in the entire study population and in the surgical group. Overall, 213 patients were admitted during the 3-year study period. Outcome was poor in 135 (63%) patients, as 65 (31%) died during their admission, 33 (15%) were in a vegetative state, and 37 (17%) had severe disability at discharge. Surgical patients had worse clinical and radiological findings on arrival or during their admission than the patients undergoing conservative treatment. Surgery was performed in 147 (69%) patients, and 114 (78%) of them had a poor outcome. In stratifying patients by their Glasgow Coma Scale (GCS) score, the authors found that surgery reduced mortality but not the frequency of a poor outcome in the patients with a moderate to severe GCS score. The GCS score and midline shift were the most significant predictors of outcome. Antiplatelet drugs were associated with better outcomes; however, patients taking such medications had a better GCS score and better radiological findings, which could have influenced the former finding. Patients with fixed pupils never had a good outcome. Age and Charlson Comorbidity Index were not associated with outcome. Traumatic ASDH in the elderly is a severe condition, with the GCS score and midline shift the stronger outcome predictors, while age per se and comorbidities were not associated with outcome. Antithrombotic drugs do not seem to negatively influence pretreatment status or posttreatment outcome. Surgery was performed in patients with a worse clinical and radiological status, reducing the rate of death but not the frequency of a poor outcome.

Identifiants

pubmed: 33002873
doi: 10.3171/2020.7.FOCUS20437
pii: 2020.7.FOCUS20437
doi:
pii:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

E21

Auteurs

Gianluca Trevisi (G)

1Neurosurgical Unit, Ospedale Santo Spirito, Pescara.

Carmelo Lucio Sturiale (CL)

2Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome.

Alba Scerrati (A)

3Department of Neurosurgery, S. Anna University Hospital, Ferrara.
4Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara.

Oriela Rustemi (O)

5UOC Neurochirurgia 1, Azienda ULSS 8 Berica Ospedale San Bortolo, Vicenza.

Luca Ricciardi (L)

6UOC di Neurochirurgia, Azienda Ospedaliera Sant'Andrea, Dipartimento NESMOS, Sapienza-Roma; and.

Fabio Raneri (F)

5UOC Neurochirurgia 1, Azienda ULSS 8 Berica Ospedale San Bortolo, Vicenza.

Alberto Tomatis (A)

1Neurosurgical Unit, Ospedale Santo Spirito, Pescara.

Amedeo Piazza (A)

6UOC di Neurochirurgia, Azienda Ospedaliera Sant'Andrea, Dipartimento NESMOS, Sapienza-Roma; and.

Anna Maria Auricchio (AM)

2Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome.

Vito Stifano (V)

2Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome.

Carmine Romano (C)

3Department of Neurosurgery, S. Anna University Hospital, Ferrara.

Pasquale De Bonis (P)

3Department of Neurosurgery, S. Anna University Hospital, Ferrara.
4Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara.

Annunziato Mangiola (A)

1Neurosurgical Unit, Ospedale Santo Spirito, Pescara.
7Department of Neurosciences, Imaging and Clinical Sciences, "G. D'Annunzio" University, Chieti, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH